<DOC>
	<DOCNO>NCT00166621</DOCNO>
	<brief_summary>The purpose study determine efficacy , safety , population pharmacokinetics determinant drug responses buspirone child autism use randomize , double blind , cross study child age 2 6 year .</brief_summary>
	<brief_title>Early Pharmacotherapy Aimed Neuroplasticity Autism : Safety Efficacy</brief_title>
	<detailed_description>Autism neurodevelopmental disorder define qualitative impairment social interaction communication restrictive stereotype pattern behavior , interest activity . Pharmacological agent increasingly use label young autistic child , virtually data regard pharmacokinetics , safety efficacy agent young child . The approach study differs pharmacotherapy study autism carry thus far several way : - rationale underlie approach base upon attempt alter synaptic plasticity postnatal development , focus young child - integrate drug trial PG study evaluate whether buspirone response relate expression gene involve serotoninergic neurotransmission - ass variables together vivo assessment serotonin synthesis capacity PET . This prospective , randomize , double blind , crossover study child stratify age two group . Treatment last 12 week dose twice day . Parent rating , cognitive test blood sample occur throughout study period .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Buspirone</mesh_term>
	<criteria>Meet study definition diagnosis autistic disorder Age 2 6 ( male female ) Informed Consent Clinical lab evidence renal hepatic disease Treatment medication know alter activity CYP3A4 enzyme include ketoconazole , itraconazole , grapefruit juice , erythromycin , clarithromycin , cimetidine , verapamil , diltiazem , rifampin , phenytoin , phenobarbital , carbamazepine within previous 3 month Use centrally act drug 6 week prior study Presence history neurological disorder , include seizure disorder</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Autism</keyword>
	<keyword>Neuroplasticity</keyword>
</DOC>